Skip to main content
Log in

Coagulation and infective endocarditis: sooner or later

  • IM - COMMENTARY
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Que YA, Moreillon P (2011) Infective endocarditis. Nat Rev Cardiol 8:322–336

    Article  CAS  PubMed  Google Scholar 

  2. Durante-Mangoni E, Molaro R, Iossa D (2014) The role of hemostasis in infective endocarditis. Curr Infect Dis Rep 16:435

    Article  PubMed  Google Scholar 

  3. Jereb M, Kotar T, Jurca T, Lejko Zupanc T (2009) Usefulness of procalcitonin for diagnosis of infective endocarditis. Intern Emerg Med 4:221–226

    Article  PubMed  Google Scholar 

  4. Berlot G, Calderan C, Fiorenza C, Cappelli D, Addesa S, Bussani R (2014) Infective and non-infective endocarditis in critically ill patients: a clinical-pathological study. Intern Emerg Med 9:773–778

    Article  PubMed  Google Scholar 

  5. Durante-Mangoni E, Utili R (2014) Nosocomial endocarditis: still a challenging diagnosis. Intern Emerg Med 9:715–716

    Article  PubMed  Google Scholar 

  6. Durante-Mangoni E, Iossa D, Molaro R et al (2015) Prevalence and significance of two major inherited thrombophilias in infective endocarditis. Intern Emerg Med. doi:10.1007/s11739-015-1214-8

    PubMed  Google Scholar 

  7. Boekholdt SM, Bijsterveld NR, Moons AH, Levi M, Büller HR, Peters RJ (2001) Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review. Circulation 104:3063–3068

    Article  CAS  PubMed  Google Scholar 

  8. Soria JM, Morange PE, Vila J et al (2014) Multilocus genetic risk scores for venous thromboembolism risk assessment. J Am Heart Assoc 3:e001060. doi:10.1161/JAHA.114.001060

    Article  PubMed Central  PubMed  Google Scholar 

  9. Kupferwasser LI, Yeaman MR, Shapiro SM et al (1999) Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effect. Circulation 99:2791–2797

    Article  CAS  PubMed  Google Scholar 

  10. Kupferwasser LI, Yeaman MR, Nast CC et al (2003) Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus. J Clin Invest 112:222–233

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Veloso TR, Que YA, Chaouch A et al (2015) Prophylaxis of experimental endocarditis with antiplatelet and antithrombin agents: a role for long-term prevention of infective endocarditis in humans? J Infect Dis 211:72–79

    Article  PubMed  Google Scholar 

  12. Anavekar NS, Tleyjeh IM, Anavekar NS et al (2007) Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis. Clin Infect Dis 44:1180–1186

    Article  PubMed  Google Scholar 

  13. Chan KL, Tam J, Dumesnil JG et al (2008) Effect of long-term aspirin use on embolic events in infective endocarditis. Clin Infect Dis 46:37–41

    Article  PubMed  Google Scholar 

  14. Jung CJ, Yeh CY, Hsu RB, Lee CM, Shun CT, Chia JS (2015) Endocarditis pathogen promotes vegetation formation by inducing intravascular neutrophil extracellular traps through activated platelets. Circulation 131:571–581

    Article  CAS  PubMed  Google Scholar 

  15. Habib G, Hoen B, Tornos P et al (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 19:2369–2413

    Google Scholar 

  16. Vanassche T, Peetermans WE, Herregods MC, Herijgers P, Verhamme P (2011) Anti-thrombotic therapy in infective endocarditis. Expert Rev Cardiovasc Ther 9:1203–1219

    Article  CAS  PubMed  Google Scholar 

  17. Santilli F, Davì G (2009) Thrombin as a common downstream target blocking both platelet and monocyte activation. Thromb Haemost 101:220–221

    CAS  PubMed  Google Scholar 

  18. Grandone E, Martinelli I, Margaglione M et al (2006) Platelet activation in subjects carrying factor V Leiden or factor II A20210 mutations. J Thromb Haemost 4:2496–2498

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors’ studies were supported by a grant from the Italian Ministry of University and Research (PRIN n. 2010JS3PMZ to FS).

Conflict of interest

The authors have no conflict of interest to disclose.

Statement of human and animal rights

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with human and animals performed by any of the authors.

Informed consent

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francesca Santilli.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Santilli, F., Simeone, P. & Davì, G. Coagulation and infective endocarditis: sooner or later. Intern Emerg Med 10, 539–541 (2015). https://doi.org/10.1007/s11739-015-1258-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-015-1258-9

Keywords

Navigation